Skip to main content

Table 2 The comparison of the dietary intake at the baseline and the end of the study in patients with IBS

From: Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome

Variables Mean ± SD
Placebo(n = 28)
Mean ± SD
Ellagic acid (n = 29)
P1
Energy(kcal) Baseline 2089.95 ± 245.09 2043.57 ± 233.11 0.307
End 2033.28 ± 237.18 2026.38 ± 292.2 0.413
P2 0.506 0.367  
Protein(gr) Baseline 86.42 ± 14.27 84.54 ± 16.41 0.508
End 82.33 ± 14.09 83.63 ± 16.22 0.419
P2 0.59 0.546  
Carbohydrate(gr) Baseline 270 ± 55.2 265.52 ± 50.04 0.502
End 263.14 ± 50.5 261.33 ± 48.13 0.58
P2 0.584 0.603  
Fat (gr) Baseline 73.80 ± 15.71 71.48 ± 14.41 0.714
End 72.37 ± 15 70.83 ± 14 0.683
P2 0.633 0.61  
Saturated fatty acids(gr) Baseline 26.2 ± 8.11 25.67 ± 9.18 0.656
End 25.32 ± 8.17 24.27 ± 7.03 0.529
P2 0.57 0.546  
Monounsaturated Fatty acid (gr) Baseline 22.11 ± 4.77 22.13 ± 3.19 0.807
End 21.3 ± 4.03 22.17 ± 3.55 0.59
P2 0.63 0.74  
Polyunsaturated Fatty acid (gr) Baseline 24.28 ± 7.64 23.18 ± 3.11 0.421
End 22.9 ± 4.07 22.27 ± 5.17 0.365
P2 0.29 0.267  
Fiber(gr) Baseline 10.51 ± 2.2 11.09 ± 3.06 0.129
End 10.67 ± 2.31 11.43 ± 2.25 0.167
P2 0.419 0.51  
Vitamin C (mg) Baseline 71.19 ± 25.69 72.38 ± 15.66 0.758
End 70.07 ± 24.16 72.29 ± 14.19 0.801
P2 0.603 0.711  
Vitamin E (IU) Baseline 10.24 ± 1.89 9.95 ± 2.5 0.309
End 10.53 ± 1.77 10.07 ± 2.27 0.22
P2 0.32 0.294  
Selenium (μg/day) Baseline 119.08 ± 35.63 120.24 ± 37.18 0.86
End 118.14 ± 38.01 120.18 ± 38.27 0.891
P2 0.883 0.805  
  1. Data are expressed as means ± SD
  2. P1: Comparison of the mean of dietary intake between the two groups of Ellagic acid and placebo (Independent samples t-test)
  3. P2: Comparison of mean of dietary intake in each group at baseline and end of study (Paired samples t-test)